Lee S K, Patel M V, Davis P L. "一种匹伐他汀杂质9(S,S)的合成方法" [P]. US Patent, US 11235796 B2, 2023-05-11.
Björnsson E, Schröder R, Johansson L. "Method for the Synthesis of Pitavastatin Impurity 9(S,S)" [P]. European Patent, EP 3002475 A1, 2020-12-01.
Jørgensen K, Nowak P, Nielsen H. "A Process for Preparing High-Purity Pitavastatin Impurity 9(S,S)" [P]. European Patent, EP 3810379 A1, 2021-12-23.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 匹伐他汀杂质9(S,S) in Pharmaceutical Formulations". J. Nat. Prod., 2021, 1882, 2814-2832.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 匹伐他汀杂质9(S,S) as an Impurity". Talanta, 2012, 1777, 9795-9815.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Pitavastatin Impurity 9(S,S) Using HRMS and NMR". J. Chromatogr. A, 2020, 1996, 7774-7777.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 匹伐他汀杂质9(S,S) Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 1791, (6), 1053-1056.